Company intelligence / Profile preview
Phoenix Biotechnology, Inc.
San Antonio, Texas, United Statesphoenixbiotechnology.com ↗
- Ownership
- Private
- Employees
- ~15
- Development stage
- Preclinical
01
Overview
Research suggests their oleandrin extract prevents key viruses from correctly forming their protective envelope, rendering virus progeny non-infective. They've also shown superior effects on innate immune functions for dermal allergic reactions in canine cells compared to oclacitinib.
- Therapeutic areas
- OncologyImmunologyNeurologyInfectious Diseases
- Modalities
- Natural product extractsNerium oleander extract (NOE)
- Industry
- Biotech
02
Drug pipeline
9 assets8 more assets in the full pipeline.
03
Partnerships
Avila Herbals, LLC (manufacturing and R&D agreement)
Beyond the preview
Go deeper on Phoenix Biotechnology, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Phoenix Biotechnology, Inc..